EU regulators reviewing Shire’s bleeding disorder drug

26th June 2017 Uncategorised 0

European regulators have validated the marketing authorisation application for Shire’s experimental von Willebrand Disease therapy Veyvondi.

More: EU regulators reviewing Shire’s bleeding disorder drug
Source: News